Abnormal cell responses and role of TNF- α in impaired diabetic wound healing

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Xu, Fanxing ^a,b   Zhang, Chenying ^b,c   Graves, Dana T ^b  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; DIABETES MELLITUS; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; KERATINOCYTE; MACROPHAGE; MESENCHYMAL STEM CELL; MYOFIBROBLAST; REVIEW; VASCULARIZATION; WOUND HEALING; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; DIABETES MELLITUS; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; MACROPHAGES; MESENCHYMAL STROMAL CELLS; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 84874628517     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/754802     Document Type: Review

References (106)

1. Narayan K. M. V., Boyle J. P., Thompson T. J., Sorensen S. W., Williamson D. F., Lifetime risk for diabetes mellitus in the United States. The Journal of the American Medical Association 2003 290 14 1884 1890 2-s2.0-0141991939 10.1001/jama.290.14.1884 (Pubitemid 37430605)
2. American Diabetes Association, Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008 31 3 596 615
3. Reinke J. M., Sorg H., Wound repair and regeneration. European Surgical Research 2012 49 1 35 43 10.1159/000339613
4. Singer A. J., Clark R. A. F., Cutaneous wound healing. The New England Journal of Medicine 1999 341 10 738 746 2-s2.0-0033517356 10.1056/ NEJM199909023411006 (Pubitemid 29407375)
5. Valluru M., Staton C. A., Reed M. W., Transforming growth factor- β and endoglin signaling orchestrate wound healing. Frontiers in Physiology 2011 2, article 89 10.3389/fphys.2011.00089
6. Blakytny R., Jude E., The molecular biology of chronic wounds and delayed healing in diabetes. Diabetic Medicine 2006 23 6 594 608 2-s2.0-33744780764 10.1111/j.1464-5491.2006.01773.x (Pubitemid 43830059)
7. Leung P., Diabetic foot ulcers-a comprehensive review. The Surgeon 2007 5 4 219 231 2-s2.0-34547808168
8. Sibbald R. G., Woo K. Y., The biology of chronic foot ulcers in persons with diabetes. Diabetes/Metabolism Research and Reviews 2008 24 1 S25 S30 2-s2.0-44949173228 10.1002/dmrr.847 (Pubitemid 351802768)
9. Tellechea A L. E., Veves A., Carvalho E., Inflammatory and angiogenic abnormalities in diabetic wound healing: role of neuropeptides and therapeutic perspectives. The Open Circulation and Vascular Journal 2010 3 43 55 10.2174/1877382601003020043
10. Gurtner G. C., Werner S., Barrandon Y., Longaker M. T., Wound repair and regeneration. Nature 2008 453 7193 314 321 2-s2.0-43749088730 10.1038/nature07039 (Pubitemid 351693137)
11. Barrientos S., Stojadinovic O., Golinko M. S., Brem H., Tomic-Canic M., Growth factors and cytokines in wound healing. Wound Repair and Regeneration 2008 16 5 585 601 2-s2.0-51349167276 10.1111/j.1524-475X.2008.00410.x
12. Wen Y., Gu J., Li S. L., Reddy M. A., Natarajan R., Nadler J. L., Elevated glucose and diabetes promote interleukin-12 cytokine gene expression in mouse macrophages. Endocrinology 2006 147 5 2518 2525 2-s2.0-33645873000 10.1210/en.2005-0519
13. Lin Z. Q., Kondo T., Ishida Y., Takayasu T., Mukaida N., Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. Journal of Leukocyte Biology 2003 73 6 713 721 2-s2.0-0038341934 10.1189/jlb.0802397 (Pubitemid 38040449)
14. Graves D. T., Nooh N., Gillen T., Davey M., Patel S., Cottrell D., Amar S., IL-1 plays a critical role in oral, but not dermal, wound healing. Journal of Immunology 2001 167 9 5316 5320 2-s2.0-0035500631 (Pubitemid 33009770)
15. Nagaoka T., Kaburagi Y., Hamaguchi Y., Hasegawa M., Takehara K., Steeber D. A., Tedder T. F., Sato S., Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. The American Journal of Pathology 2000 157 1 237 247 2-s2.0-0033897259 (Pubitemid 30641740)
16. Yukami T., Hasegawa M., Matsushita Y., Fujita T., Matsushita T., Horikawa M., Komura K., Yanaba K., Hamaguchi Y., Nagaoka T., Ogawa F., Fujimoto M., Steeber D. A., Tedder T. F., Takehara K., Sato S., Endothelial selectins regulate skin wound healing in cooperation with L-selectin and ICAM-1. Journal of Leukocyte Biology 2007 82 3 519 531 2-s2.0-34548444655 10.1189/jlb.0307152 (Pubitemid 47367142)
17. Zaja-Milatovic S., Richmond A., CXC chemokines and their receptors: a case for a significant biological role in cutaneous wound healing. Histology and Histopathology 2008 23 11 1399 1407 2-s2.0-58149134863
18. Ishida Y., Gao J. L., Murphy P. M., Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. Journal of Immunology 2008 180 1 569 579 2-s2.0-40449127195
19. Yates C. C., Whaley D., Kulasekeran P., Hancock W. W., Lu B., Bodnar R., Newsome J., Hebda P. A., Wells A., Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor. The American Journal of Pathology 2007 171 2 484 495 2-s2.0-34548321261 10.2353/ajpath.2007.061092 (Pubitemid 47344681)
20. Newman R. E., Yoo D., LeRoux M. A., Danilkovitch-Miagkova A., Treatment of inflammatory diseases with mesenchymal stem cells. Inflammation and Allergy-Drug Targets 2009 8 2 110 123 2-s2.0-70349501666 10.2174/ 187152809788462635
21. Arwert E. N., Hoste E., Watt F. M., Epithelial stem cells, wound healing and cancer. Nature Reviews Cancer 2012 12 3 170 180 10.1038/nrc3217
22. Critser P. J., Yoder M. C., Endothelial colony-forming cell role in neoangiogenesis and tissue repair. Current Opinion in Organ Transplantation 2010 15 1 68 72 2-s2.0-75749100300 10.1097/MOT.0b013e32833454b5
23. Ochoa O., Torres F. M., Shireman P. K., Chemokines and diabetic wound healing. Vascular 2007 15 6 350 355 2-s2.0-37349102632 10.2310/6670.2007.00056 (Pubitemid 350305401)
24. Chatzigeorgiou A., Harokopos V., Mylona-Karagianni C., Tsouvalas E., Aidinis V., Kamper E., The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time. Annals of Medicine 2010 42 6 426 438 2-s2.0-77955166892 10.3109/07853890.2010.495951
25. Khanna S., Biswas S., Shang Y., Collard E., Azad A., Kauh C., Bhasker V., Gordillo G. M., Sen C. K., Roy S., Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS ONE 2010 5 3 2-s2.0-77949681013 10.1371/journal.pone.0009539 e9539
26. Nwomeh B. C., Yager D. R., Cohen I. K., Physiology of the chronic wound. Clinics in Plastic Surgery 1998 25 3 341 356 2-s2.0-0031858059 (Pubitemid 28343176)
27. Wetzler C., Kampfer H., Stallmeyer B., Pfeilschifter J., Frank S., Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. Journal of Investigative Dermatology 2000 115 2 245 253 2-s2.0-0033894983 10.1046/j.1523-1747.2000.00029.x (Pubitemid 30637194)
28. Lucas T., Waisman A., Ranjan R., Roes J., Krieg T., Müller W., Roers A., Eming S. A., Differential roles of macrophages in diverse phases of skin repair. Journal of Immunology 2010 184 7 3964 3977 2-s2.0-77951631929 10.4049/jimmunol.0903356
29. Maruyama K., Asai J., Ii M., Thorne T., Losordo D. W., D'Amore P. A., Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. The American Journal of Pathology 2007 170 4 1178 1191 2-s2.0-34247874642 10.2353/ajpath.2007.060018 (Pubitemid 47339326)
30. Martinez F. O., Sica A., Mantovani A., Locati M., Macrophage activation and polarization. Frontiers in Bioscience 2008 13 2 453 461 2-s2.0-38449102676 10.2741/2692 (Pubitemid 351599757)
31. Benoit M., Desnues B., Mege J. L., Macrophage polarization in bacterial infections. Journal of Immunology 2008 181 6 3733 3739 2-s2.0-56149103896
32. Zhang X., Mosser D. M., Macrophage activation by endogenous danger signals. Journal of Pathology 2008 214 2 161 178 2-s2.0-38549136572 10.1002/path.2284 (Pubitemid 351160154)
33. Grinberg S., Hasko G., Wu D., Leibovich S. J., Suppression of PLC β 2 by endotoxin plays a role in the adenosine A 2A receptor-mediated switch of macrophages from an inflammatory to an angiogenic phenotype. The American Journal of Pathology 2009 175 6 2439 2453 2-s2.0-73549104499 10.2353/ajpath.2009.090290
34. Odegaard J. I., Chawla A., Mechanisms of macrophage activation in obesity-induced insulin resistance. Nature Clinical Practice Endocrinology and Metabolism 2008 4 11 619 626 2-s2.0-54549096762 10.1038/ncpendmet0976
35. Kanter J. E., Kramer F., Barnhart S., Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proceedings of the National Academy of Sciences of the United States of America 2012 109 12 E715 E724 10.1073/pnas.1111600109
36. Daley J. M., Brancato S. K., Thomay A. A., Reichner J. S., Albina J. E., The phenotype of murine wound macrophages. Journal of Leukocyte Biology 2010 87 1 59 67 2-s2.0-74949115952 10.1189/jlb.0409236
37. Delavary B. M., van der Veer W. M., van Egmond M., Niessen F. B., Beelen R. H. J., Macrophages in skin injury and repair. Immunobiology 2011 216 7 753 762 2-s2.0-79957598147 10.1016/j.imbio.2011.01.001
38. Mège J. L., Mehraj V., Capo C., Macrophage polarization and bacterial infections. Current Opinion in Infectious Diseases 2011 24 3 230 234 2-s2.0-79955521362 10.1097/QCO.0b013e328344b73e
39. Koh T. J., DiPietro L. A., Inflammation and wound healing: the role of the macrophage. Expert Reviews in Molecular Medicine 2011 13, article e23 10.1017/S1462399411001943
40. Fu X., Li H., Mesenchymal stem cells and skin wound repair and regeneration: possibilities and questions. Cell and Tissue Research 2009 335 2 317 321 2-s2.0-58849114463 10.1007/s00441-008-0724-3
41. Liu L., Yu Q., Lin J., Hypoxia-inducible factor-1 α is essential for hypoxia-induced mesenchymal stem cell mobilization into the peripheral blood. Stem Cells and Development 2011 20 11 1961 1971 10.1089/scd.2010.0453
42. Sasaki M., Abe R., Fujita Y., Ando S., Inokuma D., Shimizu H., Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. Journal of Immunology 2008 180 4 2581 2587 2-s2.0-42149189474
43. Wu Y., Chen L., Scott P. G., Tredget E. E., Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007 25 10 2648 2659 2-s2.0-35348831024 10.1634/stemcells.2007-0226 (Pubitemid 47582758)
44. Chen L., Tredget E. E., Wu P. Y. G., Wu Y., Wu Y., Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE 2008 3 4 2-s2.0-44849121129 10.1371/journal. pone.0001886 e1886 (Pubitemid 351943822)
45. Singer N. G., Caplan A. I., Mesenchymal stem cells: mechanisms of inflammation. Annual Review of Pathology 2011 6 457 478 2-s2.0-79751504754 10.1146/annurev-pathol-011110-130230
46. Jin P., Zhang X., Wu Y., Li L., Yin Q., Zheng L., Zhang H., Sun C., Streptozotocin-induced diabetic rat-derived bone marrow mesenchymal stem cells have impaired abilities in proliferation, paracrine, antiapoptosis, and myogenic differentiation. Transplantation Proceedings 2010 42 7 2745 2752 2-s2.0-77956467625 10.1016/j.transproceed.2010.05.145
47. Vojtassak J., Danisovic L., Kubes M., Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuro Endocrinology Letters 2006 27 supplement 2 134 137 (Pubitemid 46534356)
48. Kuo Y. R., Wang C. T., Cheng J. T., Bone marrow-derived mesenchymal stem cells enhanced diabetic wound healing through recruitment of tissue regeneration in a rat model of streptozotocin-induced diabetes. Plastic and Reconstructive Surgery 2011 128 4 872 880 10.1097/PRS.0b013e3182174329
49. Roh C., Lyle S., Cutaneous stem cells and wound healing. Pediatric Research 2006 59 4, part 2 100R 103R 2-s2.0-33646715610 10.1203/01.pdr. 0000203572.51876.ba (Pubitemid 43740043)
50. Lau K., Paus R., Tiede S., Day P., Bayat A., Exploring the role of stem cells in cutaneous wound healing. Experimental Dermatology 2009 18 11 921 933 2-s2.0-70350751513 10.1111/j.1600-0625.2009.00942.x
51. Werner S., Grose R., Regulation of wound healing by growth factors and cytokines. Physiological Reviews 2003 83 3 835 870 2-s2.0-0038676258 (Pubitemid 36828927)
52. Martin P., Wound healing-aiming for perfect skin regeneration. Science 1997 276 5309 75 81 2-s2.0-0030934532 10.1126/science.276.5309.75 (Pubitemid 27161246)
53. Galkowska H., Olszewski W. L., Wojewodzka U., Mijal J., Filipiuk E., Expression of apoptosis-and cell cycle-related proteins in epidermis of venous leg and diabetic foot ulcers. Surgery 2003 134 2 213 220 2-s2.0-0041326643 10.1067/msy.2003.223 (Pubitemid 37070341)
54. Galkowska H., Wojewodzka U., Olszewski W. L., Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers. Wound Repair and Regeneration 2006 14 5 558 565 2-s2.0-33749142760 10.1111/j.1743-6109.2006.00155.x (Pubitemid 44470072)
55. Usui M. L., Mansbridge J. N., Carter W. G., Fujita M., Olerud J. E., Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds. Journal of Histochemistry and Cytochemistry 2008 56 7 687 696 2-s2.0-45249101804 10.1369/jhc.2008.951194 (Pubitemid 351842422)
56. Lan C. C. E., Liu I. H., Fang A. H., Wen C. H., Wu C. S., Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetes. British Journal of Dermatology 2008 159 5 1103 1115 2-s2.0-54249117325 10.1111/j.1365-2133.2008.08789.x
57. Werner S., Krieg T., Smola H., Keratinocyte-fibroblast interactions in wound healing. Journal of Investigative Dermatology 2007 127 5 998 1008 2-s2.0-34247192531 10.1038/sj.jid.5700786 (Pubitemid 46625161)
58. Desta T., Li J., Chino T., Graves D. T., Altered fibroblast proliferation and apoptosis in diabetic gingival wounds. Journal of Dental Research 2010 89 6 609 614 2-s2.0-77953266361 10.1177/0022034510362960
59. Siqueira M. F., Li J., Chehab L., Desta T., Chino T., Krothpali N., Behl Y., Alikhani M., Yang J., Braasch C., Graves D. T., Impaired wound healing in mouse models of diabetes is mediated by TNF- α dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). Diabetologia 2010 53 2 378 388 2-s2.0-77949310647 10.1007/s00125-009-1529-y
60. Lamers M. L., Almeida M. E. S., Vicente-Manzanares M., Horwitz A. F., Santos M. F., High glucose-mediated oxidative stress impairs cell migration. PLoS ONE 2011 6 8 2-s2.0-79961080156 10.1371/journal.pone.0022865 e22865
61. Hehenberger K., Hansson A., Heilborn J. D., Abdel-Halim S. M., Ostensson G., Brismar K., Impaired proliferation and increased L-lactate production of dermal fibroblasts in the GK-rat, a spontaneous model of non-insulin dependent diabetes mellitus. Wound Repair and Regeneration 1999 7 1 65 71 2-s2.0-0032898831 10.1046/j.1524-475X.1999.00065.x (Pubitemid 29159042)
62. Gabbiani G., The myofibroblast in wound healing and fibrocontractive diseases. Journal of Pathology 2003 200 4 500 503 2-s2.0-0037899249 10.1002/path.1427 (Pubitemid 36818250)
63. Shephard P., Hinz B., Smola-Hess S., Meister J. J., Krieg T., Smola H., Dissecting the roles of endothelin, TGF- β and GM-CSF on myofibroblast differentiation by keratinocytes. Thrombosis and Haemostasis 2004 92 2 262 274 2-s2.0-4444236084 (Pubitemid 39172306)
64. Frank S., Madlener M., Werner S., Transforming growth factors β 1, β 2, and β 3 and their receptors are differentially regulated during normal and impaired wound healing. The Journal of Biological Chemistry 1996 271 17 10188 10193 2-s2.0-0029875396 10.1074/jbc.271.17.10188 (Pubitemid 26131583)
65. Jude E. B., Blakytny R., Bulmer J., Boulton A. J. M., Ferguson M. W. J., Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers. Diabetic Medicine 2002 19 6 440 447 2-s2.0-0035985215 10.1046/j.1464-5491.2002.00692.x (Pubitemid 34639153)
66. Al-Mulla F., Leibovich S. J., Francis I. M., Impaired TGF- β signaling and a defect in resolution of inflammation contribute to delayed wound healing in a female rat model of type 2 diabetes. Molecular Biosystems 2011 7 11 3006 3020 10.1039/c0mb00317d
67. Detmar M., Brown L. F., Berse B., Jackman R. W., Elicker B. M., Dvorak H. F., Claffey K. P., Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. Journal of Investigative Dermatology 1997 108 3 263 268 2-s2.0-0031057091 (Pubitemid 27116221)
68. Fadini G. P., Miorin M., Facco M., Bonamico S., Baesso I., Grego F., Menegolo M., Vigili de Kreutzenberg S., Tiengo A., Agostini C., Avogaro A., Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. Journal of the American College of Cardiology 2005 45 9 1449 1457 2-s2.0-20944436176 10.1016/j.jacc.2004.11.067 (Pubitemid 40615617)
69. Loomans C. J. M., de Koning E. J. P., Staal F. J. T., Rookmaaker M. B., Verseyden C., de Boer H. C., Verhaar M. C., Braam B., Rabelink T. J., Van Zonneveld A. J., Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004 53 1 195 199 2-s2.0-9144271032 10.2337/diabetes.53.1.195 (Pubitemid 38044715)
70. Sivan-Loukianova E., Awad O. A., Stepanovic V., Bickenbach J., Schatteman G. C., CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. Journal of Vascular Research 2003 40 4 368 377 2-s2.0-0141728458 10.1159/000072701 (Pubitemid 37188106)
71. Galiano R. D., Tepper O. M., Pelo C. R., Bhatt K. A., Callaghan M., Bastidas N., Bunting S., Steinmetz H. G., Gurtner G. C., Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. The American Journal of Pathology 2004 164 6 1935 1947 2-s2.0-2442717879 (Pubitemid 38669343)
72. Muller M., Trocme C., Lardy B., Morel F., Halimi S., Benhamou P. Y., Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing. Diabetic Medicine 2008 25 4 419 426 2-s2.0-41749096554 10.1111/j.1464-5491.2008.02414.x (Pubitemid 351490124)
73. Uemura S., Matsushita H., Li W., Glassford A. J., Asagami T., Lee K. H., Harrison D. G., Tsao P. S., Diabetes mellitus enhances vascular matrix metalloproteinase activity role of oxidative stress. Circulation Research 2001 88 12 1291 1298 2-s2.0-0035933381 (Pubitemid 32587846)
74. Lobmann R., Ambrosch A., Schultz G., Waldmann K., Schiweck S., Lehnert H., Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002 45 7 1011 1016 2-s2.0-0036020282 10.1007/s00125-002-0868-8 (Pubitemid 34762196)
75. Han Y. P., Tuan T. L., Wu H., Hughes M., Garner W. L., TNF- α stimulates activation of pro-MMP2 in human skin through NF- B mediated induction of MT1-MMP. Journal of Cell Science 2001 114 1 131 139 2-s2.0-0035156633 (Pubitemid 32118063)
76. Hübner G., Brauchle M., Smola H., Madlener M., Fässler R., Werner S., Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 1996 8 7 548 556 2-s2.0-0030198562 10.1006/cyto.1996.0074 (Pubitemid 26294545)
77. Ponugoti B., Dong G., Graves D. T., Role of forkhead transcription factors in diabetes-induced oxidative stress. Experimental Diabetes Research 2012 2012 7 939751 10.1155/2012/939751
78. Orr S. J., Morgan N. M., Elliott J., Burrows J. F., Scott C. J., McVicar D. W., Johnston J. A., CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover. Blood 2007 109 3 1061 1068 2-s2.0-33846864687 10.1182/blood-2006-05-023556 (Pubitemid 46220652)
79. Wallace H. J., Stacey M. C., Levels of tumor necrosis factor- α (TNF- α) and soluble TNF receptors in chronic venous leg ulcers-correlations to healing status. Journal of Investigative Dermatology 1998 110 3 292 296 2-s2.0-0031916466 10.1046/j.1523-1747.1998.00113.x (Pubitemid 28144608)
80. Harsch I. A., Brzozowski T., Bazela K., Konturek S. J., Kukharsky V., Pawlik T., Pawlowski E., Hahn E. G., Konturek P. C., Impaired gastric ulcer healing in diabetic rats: role of heat shock protein, growth factors, prostaglandins and proinflammatory cytokines. European Journal of Pharmacology 2003 481 2-3 249 260 2-s2.0-0344827152 10.1016/j.ejphar.2003.09.019 (Pubitemid 37464977)
81. Kaiser G. C., Polk D. B., Tumor necrosis factor α regulates proliferation in a mouse intestinal cell line. Gastroenterology 1997 112 4 1231 1240 2-s2.0-0030970550 10.1016/S0016-5085(97)70135-5 (Pubitemid 27157535)
82. Liu R., Bal H. S., Desta T., Behl Y., Graves D. T., Tumor necrosis factor- α mediates diabetes-enhanced apoptosis of matrix-producing cells and impairs diabetic healing. The American Journal of Pathology 2006 168 3 757 764 2-s2.0-33644654600 10.2353/ajpath.2006.050907 (Pubitemid 43327728)
83. Hasnan J., Yusof M. I., Damitri T. D., Faridah A. R., Adenan A. S., Norbaini T. H., Relationship between apoptotic markers (Bax and bcl-2) and biochemical markers in type 2 diabetes mellitus. Singapore Medical Journal 2010 51 1 50 55 2-s2.0-77950402132
84. Rai N. K., Bhan S., Ansari M., Kumar M., Shukla V. K., Tripathi K., Effect of glycaemic control on apoptosis in diabetic wounds. Journal of wound care 2005 14 6 277 281 2-s2.0-23044492214
85. Petrache I., Otterbein L. E., Alam J., Wiegand G. W., Choi A. M. K., Heme oxygenase-1 inhibits TNF- α -induced apoptosis in cultured fibroblasts. American Journal of Physiology 2000 278 2 L312 L319 2-s2.0-0034054881 (Pubitemid 30131216)
86. Ruckert R., Lindner G., Bulfone-Paus S., Paus R., High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo. British Journal of Dermatology 2000 143 5 1036 1039 2-s2.0-0033739225 10.1046/j.1365-2133.2000.03784.x
87. Brem H., Tomic-Canic M., Cellular and molecular basis of wound healing in diabetes. Journal of Clinical Investigation 2007 117 5 1219 1222 2-s2.0-34248225758 10.1172/JCI32169 (Pubitemid 46718408)
88. Corredor J., Yan F., Shen C. C., Tong W., John S. K., Wilson G., Whitehead R., Polk D. B., Tumor necrosis factor regulates intestinal epithelial cell migration by receptor-dependent mechanisms. American Journal of Physiology 2003 284 4 C953 C961 2-s2.0-0037377183 (Pubitemid 36336951)
89. Bitzer M., von Gersdorff G., Liang D., Dominguez-Rosales A., Beg A. A., Rojkind M., Böttinger E. P., A mechanism of suppression of TGF- β /SMAD signaling by NF- B/RelA. Genes and Development 2000 14 2 187 197 2-s2.0-0034650266 (Pubitemid 30070984)
90. Arancibia R., Oyarzun A., Silva D., Tnf- α inhibits Tgf- β -stimulated myofibroblastic differentiation and extracellular matrix production in human gingival fibroblasts. Journal of Periodontology. In press 10.1902/jop.2012.120225
91. Chan Y. C., Roy S., Khanna S., Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 6 1372 1382 10.1161/ATVBAHA.112.248583
92. Hotamisligil G. S., Shargill N. S., Spiegelman B. M., Adipose expression of tumor necrosis factor- α: direct role in obesity-linked insulin resistance. Science 1993 259 5091 87 91 2-s2.0-0027459878 (Pubitemid 23036092)
93. Goren I., Müller E., Pfeilschifter J., Frank S., Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor- α The American Journal of Pathology 2006 168 3 765 777 2-s2.0-33644651282 10.2353/ajpath.2006.050293 (Pubitemid 43327729)
94. Moller D. E., Potential role of TNF- α in the pathogenesis of insulin resistance and type 2 diabetes. Trends in Endocrinology and Metabolism 2000 11 6 212 217 2-s2.0-0033867178 10.1016/S1043-2760(00)00272-1 (Pubitemid 30603166)
95. Potente M., Urbich C., Sasaki K. I., Hofmann W. K., Heeschen C., Aicher A., Kollipara R., DePinho R. A., Zeiher A. M., Dimmeler S., Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. Journal of Clinical Investigation 2005 115 9 2382 2392 2-s2.0-24644519938 10.1172/JCI23126 (Pubitemid 41266200)
96. Alikhani M., Roy S., Graves D. T., FOXO1 plays an essential role in apoptosis of retinal pericytes. Molecular Vision 2010 16 408 415 2-s2.0-77952312505
97. Behl Y., Krothapalli P., Desta T., Roy S., Graves D. T., FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats. Diabetes 2009 58 4 917 925 2-s2.0-64649104157 10.2337/db08-0537
98. Alblowi J., Kayal R. A., Siqueria M., McKenzie E., Krothapalli N., McLean J., Conn J., Nikolajczyk B., Einhorn T. A., Gerstenfeld L., Graves D. T., High levels of tumor necrosis factor- α contribute to accelerated loss of cartilage in diabetic fracture healing. The American Journal of Pathology 2009 175 4 1574 1585 2-s2.0-73549115418 10.2353/ajpath.2009.090148
99. Brown J., Wang H., Suttles J., Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response via FoxO1. The Journal of Biological Chemistry 2011 286 52 44295 44305 10.1074/jbc.M111.258053
100. Goova M. T., Li J., Kislinger T., Qu W., Lu Y., Bucciarelli L. G., Nowygrod S., Wolf B. M., Caliste X., Yan S. F., Stern D. M., Schmidt A. M., Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. The American Journal of Pathology 2001 159 2 513 525 2-s2.0-0034880114 (Pubitemid 32751082)
101. Ding Y., Kantarci A., Hasturk H., Trackman P. C., Malabanan A., Van Dyke T. E., Activation of RAGE induces elevated O2-generation by mononuclear phagocytes in diabetes. Journal of Leukocyte Biology 2007 81 2 520 527 2-s2.0-33846701659 10.1189/jlb.0406262 (Pubitemid 46198404)
102. Yan S. F., Ramasamy R., Schmidt A. M., The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease. Expert Reviews in Molecular Medicine 2009 11, article e9 2-s2.0-65349167787 10.1017/ S146239940900101X
103. Peppa M., Brem H., Ehrlich P., Zhang J. G., Cai W., Li Z., Croitoru A., Thung S., Vlassara H., Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes 2003 52 11 2805 2813 2-s2.0-0242332119 10.2337/diabetes.52.11.2805 (Pubitemid 37339711)
104. Goldin A., Beckman J. A., Schmidt A. M., Creager M. A., Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006 114 6 597 605 2-s2.0-33746920337 10.1161/CIRCULATIONAHA.106. 621854 (Pubitemid 44199649)
105. Brownlee M., Cerami A., Vlassara H., Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. The New England Journal of Medicine 1988 318 20 1315 1321 2-s2.0-0023950461
106. Acosta J. B., del Barco D. G., Vera D. C., Savigne W., Lopez-Saura P., Guillen Nieto G., Schultz G. S., The pro-inflammatory environment in recalcitrant diabetic foot wounds. International Wound Journal 2008 5 4 530 539 2-s2.0-54249107613 10.1111/j.1742-481X.2008.00457.x